WallStreetZenWallStreetZen

NYSE: TEVA
Teva Pharmaceutical Industries Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Teva Pharmaceutical Industries earnings were $712.0M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest TEVA earnings report on Sep 30, 2025 announced Q3 2025 earnings of $433.0M, up 53.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TEVA reported annual earnings of -$1.6B, with 193.2% growth.

TEVA past earnings growth

How has TEVA's earnings growth performed historically?

Company
N/A
Industry
-9%
Market
55.53%
TEVA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
TEVA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

TEVA earnings history

Current Revenue
$16.8B
Current Earnings
$712.0M
Current Profit Margin
4.2%

TEVA Return on Equity

Current Company
11.1%
Current Industry
15.1%
Current Market
36.1%
TEVA's Return on Equity (11.1%)... subscribe to Premium to read more.
High Return on Equity Performance

TEVA undefined

Current Company
1.8%
Current Industry
5.6%
TEVA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TEVA announces earnings.

TEVA undefined

Current Company
6.63%
Current Industry
9.7%
TEVA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TEVA vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TEVA$2.90B$712.00M-1.16%$0.63
HLN$3.12B$1.87B+3.82%$0.41
TAK$7.33B$217.72M-16.02%$0.07
NBIX$679.20M$428.00M+33.67%$4.31
VTRS-$598.90M-$3.69BN/A-$3.09
View Top Pharmaceutical Stocks

Teva Pharmaceutical Industries Earnings Reports & History FAQ

What were Teva Pharmaceutical Industries's earnings last quarter?

On TEVA's earnings call on Invalid Date, Teva Pharmaceutical Industries (NYSE: TEVA) reported Q3 2025 earnings per share (EPS) of $0.38, up 197.44% year over year. Total TEVA earnings for the quarter were $433.00 million. In the same quarter last year, Teva Pharmaceutical Industries's earnings per share (EPS) was -$0.39.

If you're new to stock investing, here's how to buy Teva Pharmaceutical Industries stock.

Is Teva Pharmaceutical Industries profitable or losing money?

As of the last Teva Pharmaceutical Industries earnings report, Teva Pharmaceutical Industries is currently profitable. Teva Pharmaceutical Industries's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $712.00 million, a 174.24% decrease year over year.

What was TEVA's earnings growth in the past year?

As of Teva Pharmaceutical Industries's earnings date in Invalid Date, Teva Pharmaceutical Industries's earnings has grown year over year. TEVA earnings in the past year totalled $712.00 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.